Perrill Dave sold HIVE

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from C$3.7300 to C$3.8600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The weighted average price reported above was converted from the Canadian weighted average price of C$3.7765 to USD$2.7191, using an exchange rate of USD$0.72 to C$1.00.; On August 19, 2026, the Reporting Person filed a Form 4 (the "Original Filing") to report the sale of 100,000 shares of the Issuer's common stock. This Form 4/A (this "Amendment") amends the Original Filing to report the conversion and settlement of 12,500 restricted share units ("RSUs") that occurred on August 18, 2026 that was inadvertently omitted from the Original Filing. The Amendment also corrects the amount of Common Stock beneficially owned following the sale reported in the Original Filing to reflect that the Reporting Person’s ownership of these 12,500 shares. Except for the conversion of the RSUs, no additional transaction is being reported in this Amendment.